MiRNA Sequencing And Assay Market (By Product & Service: Products, Services; By Technology: Sequencing, Nanopore, Sanger, Single Molecule Real-time Seq; By Workflow: Library Preparation, Sequencing, Data Analysis & Storage; By Application: Cancer, Polyglutamine Diseases; By End-Use) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2021-2030

Chapter 1.  Introduction

1.1.  Research Objective

1.2.  Scope of the Study

1.3.  Definition

Chapter 2.  Research Methodology

2.1.  Research Approach

2.2.  Data Sources

2.3.  Assumptions & Limitations

Chapter 3.  Executive Summary

3.1.  Market Snapshot

Chapter 4.  Market Variables and Scope

4.1.  Introduction

4.2.  Market Classification and Scope

4.3.  Industry Value Chain Analysis

4.3.1.    Raw Material Procurement Analysis

4.3.2.    Sales and Distribution Channel Analysis

4.3.3.    Downstream Buyer Analysis

Chapter 5.  Market Dynamics Analysis and Trends

5.1.  Market Dynamics

5.1.1.    Market Drivers

5.1.2.    Market Restraints

5.1.3.    Market Opportunities

5.2.  Porter’s Five Forces Analysis

5.2.1.    Bargaining power of suppliers

5.2.2.    Bargaining power of buyers

5.2.3.    Threat of substitute

5.2.4.    Threat of new entrants

5.2.5.    Degree of competition

Chapter 6.  Competitive Landscape

6.1.1.    Company Market Share/Positioning Analysis

6.1.2.    Key Strategies Adopted by Players

6.1.3.    Vendor Landscape

6.1.3.1.        List of Suppliers

6.1.3.2.        List of Buyers

Chapter 7.  Global MiRNA Sequencing And Assay Market, By Product & Service Type

7.1.  MiRNA Sequencing And Assay Market, By Product & Service Type, 2020-2030

7.1.1.    Products

7.1.1.1.        Market Revenue and Forecast (2016-2030)

7.1.2.    Services

7.1.2.1.        Market Revenue and Forecast (2016-2030)

Chapter 8.  Global MiRNA Sequencing And Assay Market, By Technology Type

8.1.  MiRNA Sequencing And Assay Market, By Technology Type, 2020-2030

8.1.1.    Sequencing (Seq.) By Synthesis

8.1.1.1.        Market Revenue and Forecast (2016-2030)

8.1.2.    Seq. By Oligonucleotide Ligation and Detection (SOLiD)

8.1.2.1.        Market Revenue and Forecast (2016-2030)

8.1.3.    Nanopore Seq.

8.1.3.1.        Market Revenue and Forecast (2016-2030)

8.1.4.    Sanger Seq.

8.1.4.1.        Market Revenue and Forecast (2016-2030)

8.1.5.    Single Molecule Real-time (SMRT) Seq.

8.1.5.1.        Market Revenue and Forecast (2016-2030)

Chapter 9.  Global MiRNA Sequencing And Assay Market, By Workflow Type

9.1.  MiRNA Sequencing And Assay Market, By Workflow Type, 2020-2030

9.1.1.    Library Preparation

9.1.1.1.        Market Revenue and Forecast (2016-2030)

9.1.2.    Sequencing

9.1.2.1.        Market Revenue and Forecast (2016-2030)

9.1.3.    Data Analysis & Storage

9.1.3.1.        Market Revenue and Forecast (2016-2030)

Chapter 10.      Global MiRNA Sequencing And Assay Market, By Application Type

10.1.       MiRNA Sequencing And Assay Market, By Application Type, 2020-2030

10.1.1. Cancer

10.1.1.1.     Market Revenue and Forecast (2016-2030)

10.1.2. Polyglutamine Diseases

10.1.2.1.     Market Revenue and Forecast (2016-2030)

10.1.3. Autoimmune Disease

10.1.3.1.     Market Revenue and Forecast (2016-2030)

10.1.4. Schizophrenia

10.1.4.1.     Market Revenue and Forecast (2016-2030)

10.1.5. Others

10.1.5.1.     Market Revenue and Forecast (2016-2030)

Chapter 11.      Global MiRNA Sequencing And Assay Market, By End-use Type

11.1.       MiRNA Sequencing And Assay Market, By End-use, 2020-2030

11.1.1. Pharmaceutical & Biotechnology Industry

11.1.1.1.     Market Revenue and Forecast (2016-2030)

11.1.2. Research and Academic Institutes

11.1.2.1.     Market Revenue and Forecast (2016-2030)

11.1.3. Contract Research Organizations

11.1.3.1.     Market Revenue and Forecast (2016-2030)

Chapter 12.      Global MiRNA Sequencing And Assay Market, Regional Estimates and Trend Forecast

12.1.       North America

12.1.1. Market Revenue and Forecast, By Product & Service (2016-2030)

12.1.2. Market Revenue and Forecast, By Technology (2016-2030)

12.1.3. Market Revenue and Forecast, By Workflow (2016-2030)

12.1.4. Market Revenue and Forecast, By Application (2016-2030)

12.1.5. Market Revenue and Forecast, By End-use (2016-2030)

12.1.6. U.S.

12.1.6.1.     Market Revenue and Forecast, By Product & Service (2016-2030)

12.1.6.2.     Market Revenue and Forecast, By Technology (2016-2030)

12.1.6.3.     Market Revenue and Forecast, By Workflow (2016-2030)

12.1.6.4.     Market Revenue and Forecast, By Application (2016-2030)

12.1.7. Market Revenue and Forecast, By End-use (2016-2030)

12.1.8. Rest of North America

12.1.8.1.     Market Revenue and Forecast, By Product & Service (2016-2030)

12.1.8.2.     Market Revenue and Forecast, By Technology (2016-2030)

12.1.8.3.     Market Revenue and Forecast, By Workflow (2016-2030)

12.1.8.4.     Market Revenue and Forecast, By Application (2016-2030)

12.1.8.5.     Market Revenue and Forecast, By End-use (2016-2030)

12.2.       Europe

12.2.1. Market Revenue and Forecast, By Product & Service (2016-2030)

12.2.2. Market Revenue and Forecast, By Technology (2016-2030)

12.2.3. Market Revenue and Forecast, By Workflow (2016-2030)

12.2.4. Market Revenue and Forecast, By Application (2016-2030)

12.2.5. Market Revenue and Forecast, By End-use (2016-2030)

12.2.6. UK

12.2.6.1.     Market Revenue and Forecast, By Product & Service (2016-2030)

12.2.6.2.     Market Revenue and Forecast, By Technology (2016-2030)

12.2.6.3.     Market Revenue and Forecast, By Workflow (2016-2030)

12.2.7. Market Revenue and Forecast, By Application (2016-2030)

12.2.8. Market Revenue and Forecast, By End-use (2016-2030)

12.2.9. Germany

12.2.9.1.     Market Revenue and Forecast, By Product & Service (2016-2030)

12.2.9.2.     Market Revenue and Forecast, By Technology (2016-2030)

12.2.9.3.     Market Revenue and Forecast, By Workflow (2016-2030)

12.2.10.               Market Revenue and Forecast, By Application (2016-2030)

12.2.11.               Market Revenue and Forecast, By End-use (2016-2030)

12.2.12.               France

12.2.12.1.   Market Revenue and Forecast, By Product & Service (2016-2030)

12.2.12.2.   Market Revenue and Forecast, By Technology (2016-2030)

12.2.12.3.   Market Revenue and Forecast, By Workflow (2016-2030)

12.2.12.4.   Market Revenue and Forecast, By Application (2016-2030)

12.2.13.               Market Revenue and Forecast, By End-use (2016-2030)

12.2.14.               Rest of Europe

12.2.14.1.   Market Revenue and Forecast, By Product & Service (2016-2030)

12.2.14.2.   Market Revenue and Forecast, By Technology (2016-2030)

12.2.14.3.   Market Revenue and Forecast, By Workflow (2016-2030)

12.2.14.4.   Market Revenue and Forecast, By Application (2016-2030)

12.2.15.               Market Revenue and Forecast, By End-use (2016-2030)

12.3.       APAC

12.3.1. Market Revenue and Forecast, By Product & Service (2016-2030)

12.3.2. Market Revenue and Forecast, By Technology (2016-2030)

12.3.3. Market Revenue and Forecast, By Workflow (2016-2030)

12.3.4. Market Revenue and Forecast, By Application (2016-2030)

12.3.5. Market Revenue and Forecast, By End-use (2016-2030)

12.3.6. India

12.3.6.1.     Market Revenue and Forecast, By Product & Service (2016-2030)

12.3.6.2.     Market Revenue and Forecast, By Technology (2016-2030)

12.3.6.3.     Market Revenue and Forecast, By Workflow (2016-2030)

12.3.6.4.     Market Revenue and Forecast, By Application (2016-2030)

12.3.7. Market Revenue and Forecast, By End-use (2016-2030)

12.3.8. China

12.3.8.1.     Market Revenue and Forecast, By Product & Service (2016-2030)

12.3.8.2.     Market Revenue and Forecast, By Technology (2016-2030)

12.3.8.3.     Market Revenue and Forecast, By Workflow (2016-2030)

12.3.8.4.     Market Revenue and Forecast, By Application (2016-2030)

12.3.9. Market Revenue and Forecast, By End-use (2016-2030)

12.3.10.               Japan

12.3.10.1.   Market Revenue and Forecast, By Product & Service (2016-2030)

12.3.10.2.   Market Revenue and Forecast, By Technology (2016-2030)

12.3.10.3.   Market Revenue and Forecast, By Workflow (2016-2030)

12.3.10.4.   Market Revenue and Forecast, By Application (2016-2030)

12.3.10.5.   Market Revenue and Forecast, By End-use (2016-2030)

12.3.11.               Rest of APAC

12.3.11.1.   Market Revenue and Forecast, By Product & Service (2016-2030)

12.3.11.2.   Market Revenue and Forecast, By Technology (2016-2030)

12.3.11.3.   Market Revenue and Forecast, By Workflow (2016-2030)

12.3.11.4.   Market Revenue and Forecast, By Application (2016-2030)

12.3.11.5.   Market Revenue and Forecast, By End-use (2016-2030)

12.4.       MEA

12.4.1. Market Revenue and Forecast, By Product & Service (2016-2030)

12.4.2. Market Revenue and Forecast, By Technology (2016-2030)

12.4.3. Market Revenue and Forecast, By Workflow (2016-2030)

12.4.4. Market Revenue and Forecast, By Application (2016-2030)

12.4.5. Market Revenue and Forecast, By End-use (2016-2030)

12.4.6. GCC

12.4.6.1.     Market Revenue and Forecast, By Product & Service (2016-2030)

12.4.6.2.     Market Revenue and Forecast, By Technology (2016-2030)

12.4.6.3.     Market Revenue and Forecast, By Workflow (2016-2030)

12.4.6.4.     Market Revenue and Forecast, By Application (2016-2030)

12.4.7. Market Revenue and Forecast, By End-use (2016-2030)

12.4.8. North Africa

12.4.8.1.     Market Revenue and Forecast, By Product & Service (2016-2030)

12.4.8.2.     Market Revenue and Forecast, By Technology (2016-2030)

12.4.8.3.     Market Revenue and Forecast, By Workflow (2016-2030)

12.4.8.4.     Market Revenue and Forecast, By Application (2016-2030)

12.4.9. Market Revenue and Forecast, By End-use (2016-2030)

12.4.10.               South Africa

12.4.10.1.   Market Revenue and Forecast, By Product & Service (2016-2030)

12.4.10.2.   Market Revenue and Forecast, By Technology (2016-2030)

12.4.10.3.   Market Revenue and Forecast, By Workflow (2016-2030)

12.4.10.4.   Market Revenue and Forecast, By Application (2016-2030)

12.4.10.5.   Market Revenue and Forecast, By End-use (2016-2030)

12.4.11.               Rest of MEA

12.4.11.1.   Market Revenue and Forecast, By Product & Service (2016-2030)

12.4.11.2.   Market Revenue and Forecast, By Technology (2016-2030)

12.4.11.3.   Market Revenue and Forecast, By Workflow (2016-2030)

12.4.11.4.   Market Revenue and Forecast, By Application (2016-2030)

12.4.11.5.   Market Revenue and Forecast, By End-use (2016-2030)

12.5.       Latin America

12.5.1. Market Revenue and Forecast, By Product & Service (2016-2030)

12.5.2. Market Revenue and Forecast, By Technology (2016-2030)

12.5.3. Market Revenue and Forecast, By Workflow (2016-2030)

12.5.4. Market Revenue and Forecast, By Application (2016-2030)

12.5.5. Market Revenue and Forecast, By End-use (2016-2030)

12.5.6. Brazil

12.5.6.1.     Market Revenue and Forecast, By Product & Service (2016-2030)

12.5.6.2.     Market Revenue and Forecast, By Technology (2016-2030)

12.5.6.3.     Market Revenue and Forecast, By Workflow (2016-2030)

12.5.6.4.     Market Revenue and Forecast, By Application (2016-2030)

12.5.7. Market Revenue and Forecast, By End-use (2016-2030)

12.5.8. Rest of LATAM

12.5.8.1.     Market Revenue and Forecast, By Product & Service (2016-2030)

12.5.8.2.     Market Revenue and Forecast, By Technology (2016-2030)

12.5.8.3.     Market Revenue and Forecast, By Workflow (2016-2030)

12.5.8.4.     Market Revenue and Forecast, By Application (2016-2030)

12.5.8.5.     Market Revenue and Forecast, By End-use (2016-2030)

Chapter 13.  Company Profiles

13.1.             Thermo Fisher Scientific, Inc.

13.1.1. Company Overview

13.1.2. Product Offerings

13.1.3. Financial Performance

13.1.4. Recent Initiatives

13.2.             Illumina, Inc.

13.2.1. Company Overview

13.2.2. Product Offerings

13.2.3. Financial Performance

13.2.4. Recent Initiatives

13.3.             QIAGEN

13.3.1. Company Overview

13.3.2. Product Offerings

13.3.3. Financial Performance

13.3.4. Recent Initiatives

13.4.             PerkinElmer, Inc.

13.4.1. Company Overview

13.4.2. Product Offerings

13.4.3. Financial Performance

13.4.4. Recent Initiatives

13.5.             Abcam plc

13.5.1. Company Overview

13.5.2. Product Offerings

13.5.3. Financial Performance

13.5.4. Recent Initiatives

13.6.             New England Biolabs

13.6.1. Company Overview

13.6.2. Product Offerings

13.6.3. Financial Performance

13.6.4. Recent Initiatives

13.7.             Takara Bio Inc.

13.7.1. Company Overview

13.7.2. Product Offerings

13.7.3. Financial Performance

13.7.4. Recent Initiatives

13.8.             Lexogen GmbH

13.8.1. Company Overview

13.8.2. Product Offerings

13.8.3. Financial Performance

13.8.4. Recent Initiatives

13.9.             Norgen Biotek Corp.

13.9.1. Company Overview

13.9.2. Product Offerings

13.9.3. Financial Performance

13.9.4. Recent Initiatives

13.10.           Maravai LifeSciences

13.10.1.               Company Overview

13.10.2.               Product Offerings

13.10.3.               Financial Performance

13.10.4.               Recent Initiatives

13.11.           HTG Molecular Diagnostics, Inc

13.11.1.               Company Overview

13.11.2.               Product Offerings

13.11.3.               Financial Performance

13.11.4.               Recent Initiatives

13.12.           Meridian Bioscience, Inc.

13.12.1.               Company Overview

13.12.2.               Product Offerings

13.12.3.               Financial Performance

13.12.4.               Recent Initiatives

13.13.           System Biosciences, LLC

13.13.1.               Company Overview

13.13.2.               Product Offerings

13.13.3.               Financial Performance

13.13.4.               Recent Initiatives

Chapter 14.  Research Methodology

14.1.             Primary Research

14.2.             Secondary Research

14.3.             Assumptions

Chapter 15.  Appendix

15.1.             About Us

Glossary of Terms